MX2018012904A - Uso de beta-agonistas del receptor de la hormona tiroidea. - Google Patents
Uso de beta-agonistas del receptor de la hormona tiroidea.Info
- Publication number
- MX2018012904A MX2018012904A MX2018012904A MX2018012904A MX2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A
- Authority
- MX
- Mexico
- Prior art keywords
- agonists
- thyroid beta
- thyroid
- beta
- treating
- Prior art date
Links
- 229940125388 beta agonist Drugs 0.000 title 1
- 210000001685 thyroid gland Anatomy 0.000 title 1
- 201000011452 Adrenoleukodystrophy Diseases 0.000 abstract 1
- 208000010796 X-linked adrenoleukodystrophy Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662326431P | 2016-04-22 | 2016-04-22 | |
| PCT/US2017/029102 WO2017185083A1 (en) | 2016-04-22 | 2017-04-24 | Use of thyroid beta-agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018012904A true MX2018012904A (es) | 2019-01-31 |
Family
ID=60117062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018012904A MX2018012904A (es) | 2016-04-22 | 2017-04-24 | Uso de beta-agonistas del receptor de la hormona tiroidea. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20190134069A1 (https=) |
| EP (1) | EP3445372B1 (https=) |
| JP (1) | JP2019515915A (https=) |
| KR (1) | KR102407053B1 (https=) |
| CN (3) | CN110200978B (https=) |
| AU (2) | AU2017252122B2 (https=) |
| BR (1) | BR112018071559B1 (https=) |
| CA (1) | CA3021677C (https=) |
| MX (1) | MX2018012904A (https=) |
| WO (1) | WO2017185083A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3445373B1 (en) | 2016-04-22 | 2024-08-21 | Viking Therapeutics, Inc. | Use of thyroid beta-agonists |
| US11752161B2 (en) | 2020-03-27 | 2023-09-12 | Gannex Pharma Co., Ltd. | Pharmaceutical compositions, method of making and method of using thereof |
| JP2025520449A (ja) * | 2022-06-15 | 2025-07-03 | バイキング セラピューティクス，インコーポレーテッド | Ｘ－ａｌｄ治療のための甲状腺ベータ作動薬投与計画 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| US5091552A (en) | 1986-06-30 | 1992-02-25 | Board Of Regents, The University Of Texas System | Novel antitumor aldophosphamide analogs |
| ATE131825T1 (de) | 1990-06-13 | 1996-01-15 | Arnold Glazier | Phosphorylierte prodrugs |
| US5157027A (en) | 1991-05-13 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Bisphosphonate squalene synthetase inhibitors and method |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| ATE199906T1 (de) | 1993-06-29 | 2001-04-15 | Mitsubishi Chem Corp | Phosphonat-nukleotid ester-derivate |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| DK0999825T3 (da) | 1997-07-29 | 2004-02-09 | Alcon Lab Inc | Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater |
| US6110973A (en) | 1998-01-29 | 2000-08-29 | Sepracor | Methods for treating obesity and weight gain using optically pure (-)-bupropion |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| US20040091455A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| CA2534484A1 (en) | 2003-08-07 | 2005-02-17 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| CA2543132A1 (en) * | 2003-10-23 | 2005-05-19 | Celgene Corporation | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| CN1882327A (zh) | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| WO2006128058A2 (en) | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| CA2638753A1 (en) * | 2004-12-08 | 2006-06-15 | Sirion Therapeutics, Inc. | Methods, assays and compositions for treating retinol-related diseases |
| EP1987827A1 (en) * | 2006-02-20 | 2008-11-05 | Takeda Pharmaceutical Company Limited | Novel pharmaceutical |
| WO2011038207A1 (en) | 2009-09-25 | 2011-03-31 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyroid hormone receptor agonists and methods of use |
| HUE038366T2 (hu) * | 2010-08-16 | 2018-10-29 | Allergan Inc | Módszer szabályozó T-sejtek alfa-2B adrenerg receptor agonistákkal való aktiválásához |
| WO2014178892A1 (en) * | 2013-05-03 | 2014-11-06 | Scanlan Thomas S | Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy |
| EP3259246B1 (en) * | 2015-02-20 | 2023-03-22 | Oregon Health & Science University | Derivatives of sobetirome |
| EP3423379B1 (en) * | 2016-02-29 | 2020-04-01 | Philip Morris Products S.a.s. | Hinge-lid container and blank |
| CN109475121B (zh) * | 2016-05-18 | 2021-06-25 | 俄勒冈健康科学大学 | 苏比替罗衍生物 |
-
2017
- 2017-04-24 CA CA3021677A patent/CA3021677C/en active Active
- 2017-04-24 EP EP17786795.9A patent/EP3445372B1/en active Active
- 2017-04-24 MX MX2018012904A patent/MX2018012904A/es unknown
- 2017-04-24 KR KR1020187033321A patent/KR102407053B1/ko active Active
- 2017-04-24 BR BR112018071559-0A patent/BR112018071559B1/pt active IP Right Grant
- 2017-04-24 CN CN201910397947.3A patent/CN110200978B/zh active Active
- 2017-04-24 JP JP2018555273A patent/JP2019515915A/ja active Pending
- 2017-04-24 AU AU2017252122A patent/AU2017252122B2/en active Active
- 2017-04-24 CN CN201780038675.7A patent/CN109641003A/zh active Pending
- 2017-04-24 CN CN202110804956.7A patent/CN113730421A/zh active Pending
- 2017-04-24 US US16/095,224 patent/US20190134069A1/en not_active Abandoned
- 2017-04-24 WO PCT/US2017/029102 patent/WO2017185083A1/en not_active Ceased
-
2023
- 2023-04-14 AU AU2023202321A patent/AU2023202321B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017252122A1 (en) | 2018-11-15 |
| EP3445372A4 (en) | 2020-03-25 |
| KR20190017748A (ko) | 2019-02-20 |
| AU2023202321A1 (en) | 2023-05-11 |
| CA3021677C (en) | 2024-11-12 |
| KR102407053B1 (ko) | 2022-06-10 |
| BR112018071559B1 (pt) | 2024-02-06 |
| CN113730421A (zh) | 2021-12-03 |
| WO2017185083A1 (en) | 2017-10-26 |
| CN110200978A (zh) | 2019-09-06 |
| US20190134069A1 (en) | 2019-05-09 |
| AU2023202321B2 (en) | 2025-04-24 |
| AU2017252122B2 (en) | 2023-02-09 |
| CA3021677A1 (en) | 2017-10-26 |
| CN109641003A (zh) | 2019-04-16 |
| EP3445372B1 (en) | 2026-02-25 |
| EP3445372A1 (en) | 2019-02-27 |
| JP2019515915A (ja) | 2019-06-13 |
| CN110200978B (zh) | 2023-10-31 |
| BR112018071559A2 (pt) | 2019-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
| PH12017500877A1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| PH12016501894B1 (en) | Anti-ox40 antibodies and methods of use | |
| NZ731467A (en) | Anti-tim3 antibodies and methods of use | |
| PH12017500322A1 (en) | Anti-her2 antibodies and immunoconjugates | |
| SG10201804931QA (en) | Anti-cll-1 antibodies and immunoconjugates | |
| PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
| GB2556286A (en) | Programmable voltage reference | |
| PH12016502142A1 (en) | Anti-ptk7 antibody-drug conjugates | |
| MX2016015162A (es) | Anticuerpos anti - gpc3 e inmunoconjugados. | |
| PH12015501954A1 (en) | Anti-b7-h4 antibodies and immunoconjugates | |
| MX2017001981A (es) | Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1). | |
| MX2017005797A (es) | Receptores quimericos de antigeno anti-cldn y metodos de uso. | |
| MX2016009858A (es) | Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso. | |
| MX2020012893A (es) | Formulaciones de proteinas. | |
| PH12017501022B1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| PH12017500602A1 (en) | Methods for treating ocular conditions | |
| SG11201703991PA (en) | System for the generation of call advance data | |
| MX2018012900A (es) | Uso de beta-agonistas del receptor de la hormona tiroidea. | |
| MX2018012904A (es) | Uso de beta-agonistas del receptor de la hormona tiroidea. | |
| GEP201706795B (en) | Hexahydrofuropyrroles as pde1 inhibitors | |
| EP3094347A4 (en) | Methods for enhancing the delivery of active agents | |
| EP3285764A4 (en) | Methods for treating cryptosporidiosis using triazolopyridazines | |
| MX2016009541A (es) | Metodo para tratar vajilla. | |
| WO2016040313A3 (en) | Methods of treating cancer comprising administering a ppar-gamma agonist |